GB0425057D0 - L-tartrate salt of N-1-adamantyl-2-{3-[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]eth yl}amino)propyl]phenyl}acetamide - Google Patents

L-tartrate salt of N-1-adamantyl-2-{3-[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]eth yl}amino)propyl]phenyl}acetamide

Info

Publication number
GB0425057D0
GB0425057D0 GB0425057A GB0425057A GB0425057D0 GB 0425057 D0 GB0425057 D0 GB 0425057D0 GB 0425057 A GB0425057 A GB 0425057A GB 0425057 A GB0425057 A GB 0425057A GB 0425057 D0 GB0425057 D0 GB 0425057D0
Authority
GB
United Kingdom
Prior art keywords
hydroxy
phenyl
eth
adamantyl
acetamide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0425057A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd
Original Assignee
Pfizer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd filed Critical Pfizer Ltd
Priority to GB0425057A priority Critical patent/GB0425057D0/en
Publication of GB0425057D0 publication Critical patent/GB0425057D0/en
Priority to PCT/IB2005/003314 priority patent/WO2006051375A1/en
Priority to US11/267,741 priority patent/US20060106107A1/en
Priority to PE2005001313A priority patent/PE20061131A1/en
Priority to NL1030405A priority patent/NL1030405C2/en
Priority to GT200500328A priority patent/GT200500328A/en
Priority to TW094139768A priority patent/TW200630324A/en
Priority to ARP050104741A priority patent/AR055282A1/en
Priority to UY29207A priority patent/UY29207A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/20—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes
GB0425057A 2004-11-12 2004-11-12 L-tartrate salt of N-1-adamantyl-2-{3-[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]eth yl}amino)propyl]phenyl}acetamide Ceased GB0425057D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GB0425057A GB0425057D0 (en) 2004-11-12 2004-11-12 L-tartrate salt of N-1-adamantyl-2-{3-[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]eth yl}amino)propyl]phenyl}acetamide
PCT/IB2005/003314 WO2006051375A1 (en) 2004-11-12 2005-10-31 L-tartrate salt of n-1-adamanthyl -2-{3-[(2r)-2- ({(2r)-2-hydroxy -2- [4-hydroxy-3- (hydroxymethyl) phenyl]ethyl} amino)propyl] phenyl} acet amide
US11/267,741 US20060106107A1 (en) 2004-11-12 2005-11-04 L-tartrate salt of N-1-Adamantyl-2-{3-[(2R)-2-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)propyl] phenyl}acetamide
PE2005001313A PE20061131A1 (en) 2004-11-12 2005-11-10 SALT N-1-ADAMANTIL-2- {3 - [(2R) -2 - ({(2R) -2-HYDROXY-2- [4-HYDROXY-3- (HYDROXIMETHYL) PHENYL] ETHYL} AMINO ) PROPYL] PHENYL} ACETAMIDE
NL1030405A NL1030405C2 (en) 2004-11-12 2005-11-11 L-tartrate salt of N-1-adamantyl-2- {3 - [(2 R) -2 - ({(2 R) -2-hydroxy-2- [4-hydroxy-3- (hydroxy methyl) phenyl) ethyl}] amino) propyl) phenyl} acetamide.
GT200500328A GT200500328A (en) 2004-11-12 2005-11-11 SALT L-TARTRATO N-1-ADAMANTIL-2- {3 - [(2R) -2 - ({(2R) -2-HYDROXI-2 [4-HYDROXY-3- (HYDROXIMETHYL) PHENYL] ETIL} AMINO) PROPIL] PHENYL} ACETAMIDE.
TW094139768A TW200630324A (en) 2004-11-12 2005-11-11 L-tartrate salt of N-1-adamantyl-2-{3-[(2R)-2-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)propyl]phenyl}acetamide
ARP050104741A AR055282A1 (en) 2004-11-12 2005-11-11 SALT L-TARTRATO OF N-1- ADAMANTIL -2- {3- [(2R) -2 - ({(2R) -2-HIDROXI-2- [4- HYDROXY-3- (HYDROXIMETHYL) PHENYL] ETIL} AMINO ) PROPIL] PHENYL} ACETAMIDE
UY29207A UY29207A1 (en) 2004-11-12 2005-11-11 SALT L-TARTRATO N-1-ADAMANTIL-2- (3 - ((2R) -2 - (((2R) -2-HYDROXI-2- (4-HYDROXY-3-HYDROXIMETHYL) PHENYL) ETIL) AMINO) PROPIL) PHENYL) ACETAMIDE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0425057A GB0425057D0 (en) 2004-11-12 2004-11-12 L-tartrate salt of N-1-adamantyl-2-{3-[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]eth yl}amino)propyl]phenyl}acetamide

Publications (1)

Publication Number Publication Date
GB0425057D0 true GB0425057D0 (en) 2004-12-15

Family

ID=33523659

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0425057A Ceased GB0425057D0 (en) 2004-11-12 2004-11-12 L-tartrate salt of N-1-adamantyl-2-{3-[(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]eth yl}amino)propyl]phenyl}acetamide

Country Status (8)

Country Link
AR (1) AR055282A1 (en)
GB (1) GB0425057D0 (en)
GT (1) GT200500328A (en)
NL (1) NL1030405C2 (en)
PE (1) PE20061131A1 (en)
TW (1) TW200630324A (en)
UY (1) UY29207A1 (en)
WO (1) WO2006051375A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2320961B1 (en) * 2007-11-28 2010-03-17 Laboratorios Almirall, S.A. DERIVATIVES OF 4- (2-AMINO-1-HYDROXYETHYL) PHENOL AS BETA2 ADRENERGIC RECEIVER AGONISTS.
EP2196465A1 (en) 2008-12-15 2010-06-16 Almirall, S.A. (3-oxo)pyridazin-4-ylurea derivatives as PDE4 inhibitors
EP2228368A1 (en) 2009-03-12 2010-09-15 Almirall, S.A. Process for manufacturing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
EP2394998A1 (en) 2010-05-31 2011-12-14 Almirall, S.A. 3-(5-Amino-6-oxo-1,6-dihydropyridazin-3-yl)-biphenyl derivatives as PDE4 inhibitors
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
EP2578570A1 (en) 2011-10-07 2013-04-10 Almirall, S.A. Novel process for preparing 5-(2-{[6-(2,2-difluoro-2-phenylethoxy)hexyl]amino}-1(r)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one via novel intermediates of synthesis.
EP2641900A1 (en) 2012-03-20 2013-09-25 Almirall, S.A. Novel polymorphic Crystal forms of 5-(2-{[6-(2,2-difluoro-2-phenylethoxy) hexyl]amino}-1-(R)-hydroxyethyl)-8-hydroxyquinolin-2(1h)-one, heminapadisylate as agonist of the ß2 adrenergic receptor.
MX2020003594A (en) 2017-10-05 2021-04-07 Fulcrum Therapeutics Inc P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd.
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005523920A (en) * 2002-04-25 2005-08-11 グラクソ　グループ　リミテッド Phenetanolamine derivative
EP1460064A1 (en) * 2003-03-14 2004-09-22 Pfizer Limited Indole-2-carboxamide derivatives useful as beta-2 agonists
EP1577291A1 (en) * 2004-03-17 2005-09-21 Pfizer Limited Phenylethanolamine derivatives as beta-2 agonists

Also Published As

Publication number Publication date
NL1030405A1 (en) 2006-05-15
AR055282A1 (en) 2007-08-15
UY29207A1 (en) 2006-06-30
GT200500328A (en) 2006-06-02
TW200630324A (en) 2006-09-01
NL1030405C2 (en) 2006-12-12
WO2006051375A1 (en) 2006-05-18
PE20061131A1 (en) 2006-10-20

Similar Documents

Publication Publication Date Title
TW200630324A (en) L-tartrate salt of N-1-adamantyl-2-{3-[(2R)-2-({(2R)-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)propyl]phenyl}acetamide
IL277406A (en) Novel use of il-1beta compounds
NO20052417D0 (en) Lining driving head
ATE368639T1 (en) CRYSTALLINE FORMS OF (-)-(1R,2R)-3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)-PHENOL HYDROCHLORIDE
DK2114873T3 (en) N- [3-BROMO-4- (3- [18F] FLUORPROPOXY) -BENZYL] -GUANIDINE FOR IMAGING HEART INNERVATION
MA29109B1 (en) NOVEL 2-CYANO-3 (HALOGENO) ALCOXY-BENZENESULFONAMIDE COMPOUNDS FOR COMBATTING ANIMAL HARMFUL ORGANISMS
DK3187043T3 (en) HEAD SHOES WITH ROTARY HEEL HOLDER
EP1984384A4 (en) Conotoxin analogues, and methods for synthesis of intramolecular dicarba bridge containing peptides
PT1814843E (en) (2r)-enantiomer of dotap-chloride
IL186280A0 (en) An asymmetric synthesis of (s)-(+)-3-(aminomethyl)-5-methylhexanoic acid
DE602005002219D1 (en) Phase change ink composition containing bis-urea urethane compounds
IL172169A0 (en) Processes for preparing (2s) - 3 - (4 - {2 - [amino] - 2 - oxoethoxy}
FR2849994B1 (en) INTERNAL SOLE
ITAN20050012U1 (en) DEVICE FOR SANDING OF WALLS
BRPI0720849A2 (en) PROCESSES FOR THE PREPARATION OF (3R, 4R) -N- (4-CHLOROPHENYL) -1- (2,2-DIFLUORETYL) -N '- (2-FLUOR-4- (2-OXO-1- (2H) - PYRIDINYL) PHENYL] -3,4-PYRROLYDINADICARBOXAM IDA
ITAN20060006U1 (en) DEVICE FOR SANDING OF WALLS
DK1606246T3 (en) Process for Preparation of 2-Cyan-3-hydroxy-N- (phenyl) but-2-enamides
ATE338101T1 (en) PREPARATION OF LEATHER FOR STONE STICKING
CY2004010I1 (en) PHENYL CARBAMATE
CL2007002929A1 (en) POLYMORPH B PREPARATION PROCEDURE FOR N- {2-FLUORO-5- [3- (THIOPHEN-2-CARBON)) PIRAZOLO [1,5-A] PYRIMIDIN-7-IL] PHENYL} -N-METHYL-ACETAMIDE WHICH UNDERSTAND TO REACT (5-AMINO-1H-PIRAZOL-4-IL) -TIOFEN-2-IL-METANONE WITH N- [5- (3-DIMETHYLAMINE-ACRYLILE) -2-
PT10004T (en) PERFORMANCE OF BLOCKS FOR RETAINER WALLS
ITMI20041451A1 (en) INTERNAL SHOE PARTICULARLY FOR SPORT SHOES
ITTV20040144A1 (en) INSTRUMENT FOR MANUAL REMOVAL OF FECALOMI
ATA7612004A (en) GLOVE HOLDER FOR GOLF PLAYERS (CLIP)
ITSV20040034A1 (en) BALANCER JACKET FOR UNDERWATER ACTIVITIES

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)